Search research articles
Contact Us
Filters
Showing results (71-80 of 125) with videos related to
Page
of 13
Sort By:
The New Zealand Medical Journal
|
May 22, 2020
Cannabis-based medicinal products in arthritis, a painful conundrum
Marthe Van den Berg, Mary John, Melissa Black, et al.
Frontiers in Pharmacology
|
April 27, 2019
Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
Mikkel Søes Ibsen, David B Finlay, Monica Patel, et al.
Neurotoxicology
|
September 7, 2014
Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neurons
Andrew G Yee, Sun-Min Lee, Morag R Hunter, et al.
ACS Medicinal Chemistry Letters
|
February 21, 2019
Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor
Sameek Singh, Caitlin R M Oyagawa, Christa Macdonald, et al.
British Journal of Pharmacology
|
August 14, 2013
Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action
Erin E Cawston, William J Redmond, Courtney M Breen, et al.
Trends in Pharmacological Sciences
|
February 27, 2016
One for the Price of Two…Are Bivalent Ligands Targeting Cannabinoid Receptor Dimers Capable of Simultaneously Binding to both Receptors?
Michelle Glass, Karan Govindpani, Daniel P Furkert, et al.
European Journal of Medicinal Chemistry
|
February 7, 2018
Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment
Anna G Cooper, Christa MacDonald, Michelle Glass, et al.
ACS Pharmacology & Translational Science
|
December 16, 2022
In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1<i>H</i>-indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?
Hayley M Green, David B Finlay, Ruth A Ross, et al.
Journal of Neuroscience Methods
|
April 15, 2008
Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
Natasha L Grimsey, Catherine E Goodfellow, Emma L Scotter, et al.
Plos One
|
September 12, 2013
M1 muscarinic receptor activation mediates cell death in M1-HEK293 cells
E Scott Graham, Kerhan K Woo, Miranda Aalderink, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 125) with videos related to
Sort By:
Page
of 13
The New Zealand Medical Journal
|
May 22, 2020
Cannabis-based medicinal products in arthritis, a painful conundrum
Marthe Van den Berg, Mary John, Melissa Black, et al.
Frontiers in Pharmacology
|
April 27, 2019
Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
Mikkel Søes Ibsen, David B Finlay, Monica Patel, et al.
Neurotoxicology
|
September 7, 2014
Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neurons
Andrew G Yee, Sun-Min Lee, Morag R Hunter, et al.
ACS Medicinal Chemistry Letters
|
February 21, 2019
Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor
Sameek Singh, Caitlin R M Oyagawa, Christa Macdonald, et al.
British Journal of Pharmacology
|
August 14, 2013
Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action
Erin E Cawston, William J Redmond, Courtney M Breen, et al.
Trends in Pharmacological Sciences
|
February 27, 2016
One for the Price of Two…Are Bivalent Ligands Targeting Cannabinoid Receptor Dimers Capable of Simultaneously Binding to both Receptors?
Michelle Glass, Karan Govindpani, Daniel P Furkert, et al.
European Journal of Medicinal Chemistry
|
February 7, 2018
Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment
Anna G Cooper, Christa MacDonald, Michelle Glass, et al.
ACS Pharmacology & Translational Science
|
December 16, 2022
In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1<i>H</i>-indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?
Hayley M Green, David B Finlay, Ruth A Ross, et al.
Journal of Neuroscience Methods
|
April 15, 2008
Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
Natasha L Grimsey, Catherine E Goodfellow, Emma L Scotter, et al.
Plos One
|
September 12, 2013
M1 muscarinic receptor activation mediates cell death in M1-HEK293 cells
E Scott Graham, Kerhan K Woo, Miranda Aalderink, et al.
Page
of 13